Skip to content

Expression of miRNA-429 in tic disorders and its pathogenesis

Expression of miRNA-429 in tic disorders and its pathogenesis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041667
Enrollment
Unknown
Registered
2021-01-01
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tic disorders

Interventions

TS group:Nil
normal control group:Nil

Sponsors

Fujan Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. TS patients with normal IQ; 2. 6-12 years old; 3. Yale score indica severe.

Exclusion criteria

Exclusion criteria: 1.Patients who could not be fully evaluated at the initial assessment and / or follow-up were excluded. 2. All patients with signs of severe neurological or physiological injury were excluded.

Design outcomes

Primary

MeasureTime frame
miRNA-429;

Countries

China

Contacts

Public ContactCHEN Yanhui

Fujan Medical University Union Hospital

yanhui_0655@126.com+86 13365910296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026